Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab:
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen ; Nürnberg
Friedrich-Alexander-Universität Erlangen-Nürnberg
2020
|
| Schlagworte: | |
| Online-Zugang: | Volltext Volltext kostenfrei |
| Beschreibung: | 1 Online-Ressource |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV047104465 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 210125s2020 gw |||| o||u| ||||||eng d | ||
| 015 | |a 21,O01 |2 dnb | ||
| 016 | 7 | |a 1224354451 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-151949 |2 urn | |
| 035 | |a (OCoLC)1232516239 | ||
| 035 | |a (DE-599)DNB1224354451 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 084 | |8 2\p |a 610 |2 23sdnb | ||
| 084 | |8 1\p |a 616.994 |2 23ksdnb | ||
| 100 | 1 | |a Michel, Laura L. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab |c Laura L. Michel, Andreas D. Hartkopf, Peter A. Fasching, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Bernhard Volz, Hanna Huebner, Pauline Wimberger, Carsten Hielscher, Christoph Mundhenke, Christian Kurbacher, Rachel Wuerstlein, Michael Untch, Friedrich Overkamp, Jens Huober, Wolfgang Janni, Florin-Andrei Taran, Michael P. Lux, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Tanja N. Fehm |
| 264 | 1 | |a Erlangen ; Nürnberg |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2020 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 653 | |a advanced breast cancer | ||
| 653 | |a metastatic | ||
| 653 | |a chemotherapy | ||
| 653 | |a HER2 c-erbB2 | ||
| 653 | |a HER2/neu | ||
| 653 | |a trastuzumab | ||
| 653 | |a pertuzumab | ||
| 653 | |a T-DM1 | ||
| 700 | 1 | |a Hartkopf, Andreas D. |e Verfasser |4 aut | |
| 700 | 1 | |a Fasching, Peter A. |e Verfasser |4 aut | |
| 700 | 1 | |a Kolberg, Hans-Christian |e Verfasser |4 aut | |
| 700 | 1 | |a Hadji, Peyman |e Verfasser |4 aut | |
| 700 | 1 | |a Tesch, Hans |e Verfasser |4 aut | |
| 700 | 1 | |a Häberle, Lothar |e Verfasser |4 aut | |
| 700 | 1 | |a Ettl, Johannes |e Verfasser |4 aut | |
| 700 | 1 | |a Lüftner, Diana |e Verfasser |4 aut | |
| 700 | 1 | |a Wallwiener, Markus |e Verfasser |4 aut | |
| 700 | 1 | |a Müller, Volkmar |e Verfasser |4 aut | |
| 700 | 1 | |a Beckmann, Matthias W. |e Verfasser |4 aut | |
| 700 | 1 | |a Belleville, Erik |e Verfasser |4 aut | |
| 700 | 1 | |a Volz, Bernhard |e Verfasser |4 aut | |
| 700 | 1 | |a Huebner, Hanna |e Verfasser |4 aut | |
| 700 | 1 | |a Wimberger, Pauline |e Verfasser |4 aut | |
| 700 | 1 | |a Hielscher, Carsten |e Verfasser |4 aut | |
| 700 | 1 | |a Mundhenke, Christoph |e Verfasser |4 aut | |
| 700 | 1 | |a Kurbacher, Christian |e Verfasser |4 aut | |
| 700 | 1 | |a Wuerstlein, Rachel |e Verfasser |4 aut | |
| 700 | 1 | |a Untch, Michael |e Verfasser |4 aut | |
| 700 | 1 | |a Overkamp, Friedrich |e Verfasser |4 aut | |
| 700 | 1 | |a Huober, Jens |e Verfasser |4 aut | |
| 700 | 1 | |a Janni, Wolfgang |e Verfasser |4 aut | |
| 700 | 1 | |a Taran, Florin-Andrei |e Verfasser |4 aut | |
| 787 | 0 | 8 | |i Sonderdruck aus |t Cancers |g Vol. 12 (2020) |o 10.3390/cancers12103021 |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-151949 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://d-nb.info/1224354451/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |q application/pdf |u https://open.fau.de/handle/openfau/15194 |x Verlag |z kostenfrei |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032510770 | ||
| 883 | 0 | |8 1\p |a aepkn |c 0,99956 |d 20210102 |q DE-101 |u https://d-nb.info/provenance/plan#aepkn | |
| 883 | 0 | |8 2\p |a aepsg |c 0,99948 |d 20210102 |q DE-101 |u https://d-nb.info/provenance/plan#aepsg | |
Datensatz im Suchindex
| _version_ | 1804182133686665216 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Michel, Laura L. Hartkopf, Andreas D. Fasching, Peter A. Kolberg, Hans-Christian Hadji, Peyman Tesch, Hans Häberle, Lothar Ettl, Johannes Lüftner, Diana Wallwiener, Markus Müller, Volkmar Beckmann, Matthias W. Belleville, Erik Volz, Bernhard Huebner, Hanna Wimberger, Pauline Hielscher, Carsten Mundhenke, Christoph Kurbacher, Christian Wuerstlein, Rachel Untch, Michael Overkamp, Friedrich Huober, Jens Janni, Wolfgang Taran, Florin-Andrei |
| author_facet | Michel, Laura L. Hartkopf, Andreas D. Fasching, Peter A. Kolberg, Hans-Christian Hadji, Peyman Tesch, Hans Häberle, Lothar Ettl, Johannes Lüftner, Diana Wallwiener, Markus Müller, Volkmar Beckmann, Matthias W. Belleville, Erik Volz, Bernhard Huebner, Hanna Wimberger, Pauline Hielscher, Carsten Mundhenke, Christoph Kurbacher, Christian Wuerstlein, Rachel Untch, Michael Overkamp, Friedrich Huober, Jens Janni, Wolfgang Taran, Florin-Andrei |
| author_role | aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
| author_sort | Michel, Laura L. |
| author_variant | l l m ll llm a d h ad adh p a f pa paf h c k hck p h ph h t ht l h lh j e je d l dl m w mw v m vm m w b mw mwb e b eb b v bv h h hh p w pw c h ch c m cm c k ck r w rw m u mu f o fo j h jh w j wj f a t fat |
| building | Verbundindex |
| bvnumber | BV047104465 |
| collection | ebook |
| ctrlnum | (OCoLC)1232516239 (DE-599)DNB1224354451 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03713nmm a2200793zc 4500</leader><controlfield tag="001">BV047104465</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">210125s2020 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">21,O01</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1224354451</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-151949</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1232516239</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1224354451</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">616.994</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Michel, Laura L.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab</subfield><subfield code="c">Laura L. Michel, Andreas D. Hartkopf, Peter A. Fasching, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Bernhard Volz, Hanna Huebner, Pauline Wimberger, Carsten Hielscher, Christoph Mundhenke, Christian Kurbacher, Rachel Wuerstlein, Michael Untch, Friedrich Overkamp, Jens Huober, Wolfgang Janni, Florin-Andrei Taran, Michael P. Lux, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Tanja N. Fehm</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen ; Nürnberg</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">advanced breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastatic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HER2 c-erbB2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HER2/neu</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">trastuzumab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pertuzumab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">T-DM1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hartkopf, Andreas D.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fasching, Peter A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kolberg, Hans-Christian</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hadji, Peyman</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tesch, Hans</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Häberle, Lothar</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ettl, Johannes</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lüftner, Diana</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wallwiener, Markus</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Müller, Volkmar</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Beckmann, Matthias W.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Belleville, Erik</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Volz, Bernhard</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huebner, Hanna</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wimberger, Pauline</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hielscher, Carsten</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mundhenke, Christoph</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kurbacher, Christian</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wuerstlein, Rachel</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Untch, Michael</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Overkamp, Friedrich</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huober, Jens</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Janni, Wolfgang</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Taran, Florin-Andrei</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">Cancers</subfield><subfield code="g">Vol. 12 (2020)</subfield><subfield code="o">10.3390/cancers12103021</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-151949</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://d-nb.info/1224354451/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="q">application/pdf</subfield><subfield code="u">https://open.fau.de/handle/openfau/15194</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032510770</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">aepkn</subfield><subfield code="c">0,99956</subfield><subfield code="d">20210102</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepkn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">aepsg</subfield><subfield code="c">0,99948</subfield><subfield code="d">20210102</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepsg</subfield></datafield></record></collection> |
| id | DE-604.BV047104465 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T16:24:06Z |
| indexdate | 2024-07-10T09:02:42Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032510770 |
| oclc_num | 1232516239 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| record_format | marc |
| spelling | Michel, Laura L. Verfasser aut Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab Laura L. Michel, Andreas D. Hartkopf, Peter A. Fasching, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Bernhard Volz, Hanna Huebner, Pauline Wimberger, Carsten Hielscher, Christoph Mundhenke, Christian Kurbacher, Rachel Wuerstlein, Michael Untch, Friedrich Overkamp, Jens Huober, Wolfgang Janni, Florin-Andrei Taran, Michael P. Lux, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Tanja N. Fehm Erlangen ; Nürnberg Friedrich-Alexander-Universität Erlangen-Nürnberg 2020 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager advanced breast cancer metastatic chemotherapy HER2 c-erbB2 HER2/neu trastuzumab pertuzumab T-DM1 Hartkopf, Andreas D. Verfasser aut Fasching, Peter A. Verfasser aut Kolberg, Hans-Christian Verfasser aut Hadji, Peyman Verfasser aut Tesch, Hans Verfasser aut Häberle, Lothar Verfasser aut Ettl, Johannes Verfasser aut Lüftner, Diana Verfasser aut Wallwiener, Markus Verfasser aut Müller, Volkmar Verfasser aut Beckmann, Matthias W. Verfasser aut Belleville, Erik Verfasser aut Volz, Bernhard Verfasser aut Huebner, Hanna Verfasser aut Wimberger, Pauline Verfasser aut Hielscher, Carsten Verfasser aut Mundhenke, Christoph Verfasser aut Kurbacher, Christian Verfasser aut Wuerstlein, Rachel Verfasser aut Untch, Michael Verfasser aut Overkamp, Friedrich Verfasser aut Huober, Jens Verfasser aut Janni, Wolfgang Verfasser aut Taran, Florin-Andrei Verfasser aut Sonderdruck aus Cancers Vol. 12 (2020) 10.3390/cancers12103021 https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-151949 Resolving-System kostenfrei Volltext https://d-nb.info/1224354451/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext application/pdf https://open.fau.de/handle/openfau/15194 Verlag kostenfrei 1\p aepkn 0,99956 20210102 DE-101 https://d-nb.info/provenance/plan#aepkn 2\p aepsg 0,99948 20210102 DE-101 https://d-nb.info/provenance/plan#aepsg |
| spellingShingle | Michel, Laura L. Hartkopf, Andreas D. Fasching, Peter A. Kolberg, Hans-Christian Hadji, Peyman Tesch, Hans Häberle, Lothar Ettl, Johannes Lüftner, Diana Wallwiener, Markus Müller, Volkmar Beckmann, Matthias W. Belleville, Erik Volz, Bernhard Huebner, Hanna Wimberger, Pauline Hielscher, Carsten Mundhenke, Christoph Kurbacher, Christian Wuerstlein, Rachel Untch, Michael Overkamp, Friedrich Huober, Jens Janni, Wolfgang Taran, Florin-Andrei Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab |
| title | Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab |
| title_auth | Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab |
| title_exact_search | Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab |
| title_exact_search_txtP | Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab |
| title_full | Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab Laura L. Michel, Andreas D. Hartkopf, Peter A. Fasching, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Bernhard Volz, Hanna Huebner, Pauline Wimberger, Carsten Hielscher, Christoph Mundhenke, Christian Kurbacher, Rachel Wuerstlein, Michael Untch, Friedrich Overkamp, Jens Huober, Wolfgang Janni, Florin-Andrei Taran, Michael P. Lux, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Tanja N. Fehm |
| title_fullStr | Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab Laura L. Michel, Andreas D. Hartkopf, Peter A. Fasching, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Bernhard Volz, Hanna Huebner, Pauline Wimberger, Carsten Hielscher, Christoph Mundhenke, Christian Kurbacher, Rachel Wuerstlein, Michael Untch, Friedrich Overkamp, Jens Huober, Wolfgang Janni, Florin-Andrei Taran, Michael P. Lux, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Tanja N. Fehm |
| title_full_unstemmed | Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab Laura L. Michel, Andreas D. Hartkopf, Peter A. Fasching, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Bernhard Volz, Hanna Huebner, Pauline Wimberger, Carsten Hielscher, Christoph Mundhenke, Christian Kurbacher, Rachel Wuerstlein, Michael Untch, Friedrich Overkamp, Jens Huober, Wolfgang Janni, Florin-Andrei Taran, Michael P. Lux, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Tanja N. Fehm |
| title_short | Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab |
| title_sort | progression free survival and overall survival in patients with advanced her2 positive breast cancer treated with trastuzumab emtansine t dm1 after previous treatment with pertuzumab |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-151949 https://d-nb.info/1224354451/34 https://open.fau.de/handle/openfau/15194 |
| work_keys_str_mv | AT michellaural progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT hartkopfandreasd progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT faschingpetera progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT kolberghanschristian progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT hadjipeyman progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT teschhans progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT haberlelothar progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT ettljohannes progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT luftnerdiana progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT wallwienermarkus progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT mullervolkmar progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT beckmannmatthiasw progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT bellevilleerik progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT volzbernhard progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT huebnerhanna progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT wimbergerpauline progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT hielschercarsten progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT mundhenkechristoph progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT kurbacherchristian progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT wuerstleinrachel progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT untchmichael progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT overkampfriedrich progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT huoberjens progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT janniwolfgang progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab AT taranflorinandrei progressionfreesurvivalandoverallsurvivalinpatientswithadvancedher2positivebreastcancertreatedwithtrastuzumabemtansinetdm1afterprevioustreatmentwithpertuzumab |